The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Cancer statistics for the year 2020: An overview
Open accessAbstract
Our study briefly reviews the data sources and methods used in compiling the International Agency for Research on Cancer (IARC) GLOBOCAN cancer statistics for the year 2020 and summarises the main results. National estimates were calculated based on the best available data on cancer incidence from population‐based cancer registries (PBCR) and mortality from the World Health Organization mortality database. Cancer incidence and mortality rates for 2020 by sex and age groups were estimated for 38 cancer sites and 185 countries or territories worldwide. There were an estimated 19.3 million (95% uncertainty interval [UI]: 19.0‐19.6 million) new cases of cancer (18.1 million excluding non‐melanoma skin cancer) and almost 10.0 million (95% UI: 9.7‐10.2 million) deaths from cancer (9.9 million excluding non‐melanoma skin cancer) worldwide in 2020. The most commonly diagnosed cancers worldwide were female breast cancer (2.26 million cases), lung (2.21) and prostate cancers (1.41); the most common causes of cancer death were lung (1.79 million deaths), liver (830000) and stomach cancers (769000).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sung, H., Ferlay, J., Siegel, R. L., Laversanne, M., Soerjomataram, I., Jemal, A., & Bray, F. (2021) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21660 · Cited by 108,699
Self-citationCancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
Ferlay, J., Soerjomataram, I., Dikshit, R., Eser, S., Mathers, C., Rebelo, M., Parkin, D. M., Forman, D., & Bray, F. (2015) · International Journal of Cancer · doi:10.1002/ijc.29210 · Cited by 28,766
Self-citationEstimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods
Ferlay, J., Colombet, M., Soerjomataram, I., Mathers, C., Parkin, D. M., Piñeros, M., Znaor, A., & Bray, F. (2019) · International Journal of Cancer · doi:10.1002/ijc.31937 · Cited by 7,553
Self-citationCancer Incidence in Five Continents
(1966) · doi:10.1007/978-3-642-85849-9 · Cited by 5,936
The United Nations Development Programme
Oestreich, J. E. (2017) · Development and Human Rights · doi:10.1093/acprof:oso/9780190637347.003.0003 · Cited by 4,894
International Statistical Classification of Diseases and Related Health Problems
(2011) · Encyclopedia of Clinical Neuropsychology · doi:10.1007/978-0-387-79948-3_3055 · Cited by 4,151
Ferlay, J., Colombet, M., Soerjomataram, I., Dyba, T., Randi, G., Bettio, M., Gavin, A., Visser, O., & Bray, F. (2018) · European Journal of Cancer · doi:10.1016/j.ejca.2018.07.005 · Cited by 2,478
Self-citationWorldwide Thyroid-Cancer Epidemic? The Increasing Impact of Overdiagnosis
Vaccarella, S., Franceschi, S., Bray, F., Wild, C. P., Plummer, M., & Dal Maso, L. (2016) · New England Journal of Medicine · doi:10.1056/nejmp1604412 · Cited by 1,145
Self-citationCancer mortality for selected sites in 24 countries
栗原, 登., & 瀬木, 三. (1960) · Medical Entomology and Zoology · Cited by 871
Kaufman, H. W., Chen, Z., Niles, J., & Fesko, Y. (2020) · JAMA Network Open · doi:10.1001/jamanetworkopen.2020.17267 · Cited by 400
Cited by
Bray, F., Laversanne, M., Sung, H., Ferlay, J., Siegel, R. L., Soerjomataram, I., & Jemal, A. (2024) · CA: a cancer journal for clinicians · doi:10.3322/caac.21834 · Cited by 27,064
Self-citationCancer statistics in China and United States, 2022: profiles, trends, and determinants
Xia, C., Dong, X., Li, H., Cao, M., Sun, D., He, S., Yang, F., Yan, X., Zhang, S., Li, N., et al. (2022) · Chinese Medical Journal · doi:10.1097/cm9.0000000000002108 · Cited by 3,402
Current and future burden of breast cancer: Global statistics for 2020 and 2040
Arnold, M., Morgan, E., Rumgay, H., Mafra, A., Singh, D., Laversanne, M., Vignat, J., Gralow, J. R., Cardoso, F., Siesling, S., et al. (2022) · The Breast · doi:10.1016/j.breast.2022.08.010 · Cited by 3,411
“The methods used to derive the 2020 estimates correspond to those used in previous years [7–9]; where applicable, priority is given to short-term predictions and modelled mortality to incidence (M:I) ratios, while validity is dependent on the degree of representativeness and quality of the source information [4].”
BackgroundMethodInfluentialSelf-citationGlobal burden of colorectal cancer in 2020 and 2040: incidence and mortality estimates from GLOBOCAN
Morgan, E., Arnold, M., Gini, A., Lorenzoni, V, Cabasag, C. J., Laversanne, M., Vignat, J., Ferlay, J., Murphy, N., & Bray, F. (2023) · Gut · doi:10.1136/gutjnl-2022-327736 · Cited by 2,429
Self-citationCancer incidence and mortality in China, 2022
Han, B., Zheng, R., Zeng, H., Wang, S., Sun, K., Chen, R., Li, L., Wei, W., & He, J. (2024) · Journal of the National Cancer Center · doi:10.1016/j.jncc.2024.01.006 · Cited by 2,243
Global burden of primary liver cancer in 2020 and predictions to 2040
Rumgay, H., Arnold, M., Ferlay, J., Lesi, O., Cabasag, C. J., Vignat, J., Laversanne, M., McGlynn, K. A., & Soerjomataram, I. (2022) · Journal of Hepatology · doi:10.1016/j.jhep.2022.08.021 · Cited by 2,197
Self-citationAASLD Practice Guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma
Singal, A. G., Llovet, J. M., Yarchoan, M., Mehta, N., Heimbach, J. K., Dawson, L. A., Jou, J. H., Kulik, L. M., Agopian, V. G., Marrero, J. A., et al. (2023) · Hepatology · doi:10.1097/hep.0000000000000466 · Cited by 2,052
Singh, D., Vignat, J., Lorenzoni, V., Eslahi, M., Ginsburg, O., Lauby-Secretan, B., Arbyn, M., Basu, P., Bray, F., & Vaccarella, S. (2023) · The Lancet Global Health · doi:10.1016/s2214-109x(22)00501-0 · Cited by 1,616
Self-citationManagement of Helicobacter pylori infection: the Maastricht VI/Florence consensus report
Malfertheiner, P., Megraud, F., Rokkas, T., Gisbert, J. P., Liou, J.-M., Schulz, C., Gasbarrini, A., Hunt, R. H., Leja, M., O'Morain, C., et al. (2022) · Gut · doi:10.1136/gutjnl-2022-327745 · Cited by 1,533
Global Burden of Cutaneous Melanoma in 2020 and Projections to 2040
Arnold, M., Singh, D., Laversanne, M., Vignat, J., Vaccarella, S., Meheus, F., Cust, A. E., de Vries, E., Whiteman, D. C., & Bray, F. (2022) · JAMA Dermatology · doi:10.1001/jamadermatol.2022.0160 · Cited by 1,484
Self-citationMorgan, E., Soerjomataram, I., Rumgay, H., Coleman, H. G., Thrift, A. P., Vignat, J., Laversanne, M., Ferlay, J., & Arnold, M. (2022) · Gastroenterology · doi:10.1053/j.gastro.2022.05.054 · Cited by 1,199
Self-citationGlobal patterns and trends in breast cancer incidence and mortality across 185 countries
Kim, J., Harper, A., McCormack, V., Sung, H., Houssami, N., Morgan, E., Mutebi, M., Garvey, G., Soerjomataram, I., & Fidler-Benaoudia, M. M. (2025) · Nature Medicine · doi:10.1038/s41591-025-03502-3 · Cited by 1,163
Self-citationFilho, A. M., Laversanne, M., Ferlay, J., Colombet, M., Piñeros, M., Znaor, A., Parkin, D. M., Soerjomataram, I., & Bray, F. (2025) · International Journal of Cancer · doi:10.1002/ijc.35278 · Cited by 892
Self-citation2022 Update on Prostate Cancer Epidemiology and Risk Factors—A Systematic Review
Bergengren, O., Pekala, K. R., Matsoukas, K., Fainberg, J., Mungovan, S. F., Bratt, O., Bray, F., Brawley, O., Luckenbaugh, A. N., Mucci, L., et al. (2023) · European Urology · doi:10.1016/j.eururo.2023.04.021 · Cited by 848
Self-citationMorgan, E., Arnold, M., Camargo, M. C., Gini, A., Kunzmann, A. T., Matsuda, T., Meheus, F., Verhoeven, R. H. A., Vignat, J., Laversanne, M., et al. (2022) · eClinicalMedicine · doi:10.1016/j.eclinm.2022.101404 · Cited by 773
Self-citationLong, G. V., Swetter, S. M., Menzies, A. M., Gershenwald, J. E., & Scolyer, R. A. (2023) · The Lancet · doi:10.1016/s0140-6736(23)00821-8 · Cited by 746
The Lancet Commission on prostate cancer: planning for the surge in cases
James, N. D., Tannock, I., N'Dow, J., Feng, F., Gillessen, S., Ali, S. A., Trujillo, B., Al-Lazikani, B., Attard, G., Bray, F., et al. (2024) · The Lancet · doi:10.1016/s0140-6736(24)00651-2 · Cited by 738
Self-citationPizzato, M., Li, M., Vignat, J., Laversanne, M., Singh, D., La Vecchia, C., & Vaccarella, S. (2022) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(22)00035-3 · Cited by 658
Epidemiology and Prevention of Prostate Cancer
Gandaglia, G., Leni, R., Bray, F., Fleshner, N., Freedland, S. J., Kibel, A., Stattin, P., Van Poppel, H., & La Vecchia, C. (2021) · European Urology Oncology · doi:10.1016/j.euo.2021.09.006 · Cited by 611
Self-citationEpidemiology of Bladder Cancer in 2023: A Systematic Review of Risk Factors
Jubber, I., Ong, S., Bukavina, L., Black, P. C., Compérat, E., Kamat, A. M., Kiemeney, L., Lawrentschuk, N., Lerner, S. P., Meeks, J. J., et al. (2023) · European Urology · doi:10.1016/j.eururo.2023.03.029 · Cited by 521
Self-citationEpidemiology of stomach cancer
Ilic, M., & Ilic, I. (2022) · World Journal of Gastroenterology · doi:10.3748/wjg.v28.i12.1187 · Cited by 488
Global Disparities of Cancer and Its Projected Burden in 2050
Bizuayehu, H. M., Ahmed, K. Y., Kibret, G. D., Dadi, A. F., Belachew, S. A., Bagade, T., Tegegne, T. K., Venchiarutti, R. L., Kibret, K. T., Hailegebireal, A. H., et al. (2024) · JAMA Network Open · doi:10.1001/jamanetworkopen.2024.43198 · Cited by 407
Wahab, S., Annadurai, S., Abullais, S. S., Das, G., Ahmad, W., Ahmad, M. F., Kandasamy, G., Vasudevan, R., Ali, M. S., & Amir, M. (2021) · Plants · doi:10.3390/plants10122751 · Cited by 402
Chunarkar-Patil, P., Kaleem, M., Mishra, R., Ray, S., Ahmad, A., Verma, D., Bhayye, S., Dubey, R., Singh, H., & Kumar, S. (2024) · Biomedicines · doi:10.3390/biomedicines12010201 · Cited by 390
Zhou, J., Xu, Y., Liu, J., Feng, L., Yu, J., & Chen, D. (2024) · Cancer Epidemiology · doi:10.1016/j.canep.2024.102693 · Cited by 389
Lian, M. Q., Chng, W. H., Liang, J., Yeo, H. Q., Lee, C. K., Belaid, M., Tollemeto, M., Wacker, M. G., Czarny, B., & Pastorin, G. (2022) · Journal of Extracellular Vesicles · doi:10.1002/jev2.12283 · Cited by 388
Liquid biopsies: the future of cancer early detection
Connal, S., Cameron, J. M., Sala, A., Brennan, P. M., Palmer, D. S., Palmer, J. D., Perlow, H., & Baker, M. J. (2023) · Journal of Translational Medicine · doi:10.1186/s12967-023-03960-8 · Cited by 370
Plant Extracts Mediated Metal-Based Nanoparticles: Synthesis and Biological Applications
Adeyemi, J. O., Oriola, A. O., Onwudiwe, D. C., & Oyedeji, A. O. (2022) · Biomolecules · doi:10.3390/biom12050627 · Cited by 367
Signaling pathways and therapeutic interventions in gastric cancer
Lei, Z.-N., Teng, Q.-X., Tian, Q., Chen, W., Xie, Y., Wu, K., Zeng, Q., Zeng, L., Pan, Y., Chen, Z.-S., et al. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01190-w · Cited by 322
Carbon Quantum Dots: Properties, Preparation, and Applications
Kong, J., Wei, Y., Zhou, F., Shi, L., Zhao, S., Wan, M., & Zhang, X. (2024) · Molecules · doi:10.3390/molecules29092002 · Cited by 311
Yang, J., Mo, J., Dai, J., Ye, C., Cen, W., Zheng, X., Jiang, L., & Ye, L. (2021) · Cell Death & Disease · doi:10.1038/s41419-021-04367-3 · Cited by 300
“INTRODUCTION Colorectal cancer (CRC) is the third most deadly cancer in the world [1, 2].”
BackgroundCabasag, C. J., Fagan, P. J., Ferlay, J., Vignat, J., Laversanne, M., Liu, L., van der Aa, M. A., Bray, F., & Soerjomataram, I. (2022) · International Journal of Cancer · doi:10.1002/ijc.34002 · Cited by 292
Self-citationBray, F., Parkin, D. M., Gnangnon, F., Tshisimogo, G., Peko, J.-F., Adoubi, I., Assefa, M., Bojang, L., Awuah, B., Koulibaly, M., et al. (2022) · The Lancet Oncology · doi:10.1016/s1470-2045(22)00270-4 · Cited by 282
Self-citationSharma, R. (2022) · International Journal of Clinical Oncology · doi:10.1007/s10147-021-02108-2 · Cited by 265
Gajbhiye, K. R., Salve, R., Narwade, M., Sheikh, A., Kesharwani, P., & Gajbhiye, V. (2023) · Molecular Cancer · doi:10.1186/s12943-023-01849-0 · Cited by 262
Alberts, A., Moldoveanu, E.-T., Niculescu, A.-G., & Grumezescu, A. M. (2025) · Molecules · doi:10.3390/molecules30030748 · Cited by 161
Mitochondrial CPT1A: Insights into structure, function, and basis for drug development
Liang, K. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1160440 · Cited by 156
“21 million) for the first time to take the top place among all cancers, according to the International Agency for Research on Cancer’s (IARC) estimate of the global cancer (Ferlay et al., 2021).”
BackgroundLandgren, O., Prior, T. J., Masterson, T., Heuck, C., Bueno, O. F., Dash, A. B., Einsele, H., Goldschmidt, H., Knop, S., Li, C., et al. (2024) · Blood · doi:10.1182/blood.2024024371 · Cited by 131
Doxorubicin-induced cardiotoxicity: causative factors and possible interventions
Jones, I. C., & Dass, C. R. (2022) · Journal of Pharmacy and Pharmacology · doi:10.1093/jpp/rgac063 · Cited by 91
A Review on Annona muricata and Its Anticancer Activity
Ilango, S., Sahoo, D. K., Paital, B., Kathirvel, K., Gabriel, J. I., Subramaniam, K., Jayachandran, P., Dash, R. K., Hati, A. K., Behera, T. R., et al. (2022) · Cancers · doi:10.3390/cancers14184539 · Cited by 91
Sathekge, M., Bruchertseifer, F., Vorster, M., Lawal, I. O., Knoesen, O., Mahapane, J., Davis, C., Mdlophane, A., Maes, A., Mokoala, K., et al. (2022) · Journal of Nuclear Medicine · doi:10.2967/jnumed.121.263618 · Cited by 81
“Prostate cancer is the second most frequent malignancy (after lung cancer) in men worldwide, accounting for approximately 4% of all deaths caused by cancer in men (1,2).”
BackgroundAn Overview of Potential Natural Photosensitizers in Cancer Photodynamic Therapy
Aziz, B., Aziz, I., Khurshid, A., Raoufi, E., Esfahani, F. N., Jalilian, Z., Mozafari, M. R., Taghavi, E., & Ikram, M. (2023) · Biomedicines · doi:10.3390/biomedicines11010224 · Cited by 70
“It is a leading cause of death worldwide and it has a very high impact on global health [1].”
BackgroundVallone, F., Lemmo, D., Martino, M. L., Donizzetti, A. R., Freda, M. F., Palumbo, F., Lorenzo, E., D’Argenzio, A., & Caso, D. (2022) · Psycho-Oncology · doi:10.1002/pon.5997 · Cited by 65
Elkefi, S., Trapani, D., & Ryan, S. (2023) · International Journal of Medical Informatics · doi:10.1016/j.ijmedinf.2023.105065 · Cited by 64
The Role of Solute Carrier Transporters in Efficient Anticancer Drug Delivery and Therapy
Puris, E., Fricker, G., & Gynther, M. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15020364 · Cited by 58
Brown, D., Loeliger, J., Stewart, J., Graham, K. L., Goradia, S., Gerges, C., Lyons, S., Connor, M., Stewart, S., Di Giovanni, A., et al. (2023) · Clinical Nutrition · doi:10.1016/j.clnu.2023.01.012 · Cited by 57
Li, Y., Wang, Z., Gao, P., Cao, D., Dong, R., Zhu, M., Fei, Y., Zuo, X., & Cai, J. (2024) · Journal of Translational Medicine · doi:10.1186/s12967-024-05498-9 · Cited by 55
“The mortality rate of male patients with GC is twice than that of female patients [3].”
BackgroundWéber, A., Morgan, E., Vignat, J., Laversanne, M., Pizzato, M., Rumgay, H., Singh, D., Nagy, P., Kenessey, I., Soerjomataram, I., et al. (2023) · BMJ Open · doi:10.1136/bmjopen-2022-065303 · Cited by 55
Self-citationAssociations of Dietary Intakes with Gynecological Cancers: Findings from a Cross-Sectional Study
Zhu, G., Li, Z., Tang, L., Shen, M., Zhou, Z., Wei, Y., Zhao, Y., Bai, S., & Song, L. (2022) · Nutrients · doi:10.3390/nu14235026 · Cited by 52
Charles, C., Bardet, A., Larive, A., Gorwood, P., Ramoz, N., Thomas, E., Viari, A., Rousseau-Tsangaris, M., Dumas, A., Menvielle, G., et al. (2022) · JAMA Network Open · doi:10.1001/jamanetworkopen.2022.5118 · Cited by 50
Digital PCR: From early developments to its future application in clinics
Trouchet, A., Gines, G., Benhaim, L., & Taly, V. (2025) · Lab on a Chip · doi:10.1039/d5lc00055f · Cited by 43
Hypoxia-induced cancer cell reprogramming: a review on how cancer stem cells arise
Abd, G. M., Laird, M. C., Ku, J. C., & Li, Y. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1227884 · Cited by 41
Salemi, M., Mogavero, M. P., Lanza, G., Mongioì, L. M., Calogero, A. E., & Ferri, R. (2022) · Cells · doi:10.3390/cells11121930 · Cited by 39
Liposome-based anchoring and core-encapsulation for combinatorial cancer therapy
Xiao, Q., Li, X., Liu, C., Yang, Y., Hou, Y., Wang, Y., Su, M., & He, W. (2022) · Chinese Chemical Letters · doi:10.1016/j.cclet.2022.01.083 · Cited by 38
Kiani Shahvandi, M., Souri, M., Tavasoli, S., Moradi Kashkooli, F., Kar, S., & Soltani, M. (2023) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2023.107574 · Cited by 37
Yusoh, N. A., Ahmad, H., Vallis, K. A., & Gill, M. R. (2025) · Medical Oncology · doi:10.1007/s12032-025-02812-3 · Cited by 40
“Cancer remains a burden on society due to its high mortality and morbidity, as well as the economic strain it places on healthcare systems [1, 2].”
Jian, C., Wu, T., Wang, L., Gao, C., Fu, Z., Zhang, Q., & Shi, C. (2024) · Small · doi:10.1002/smll.202309279 · Cited by 33
Kim, Y., Park, J. Y., Hwang, E. J., Lee, S. M., & Park, C. M. (2021) · Journal of Thoracic Disease · doi:10.21037/jtd-21-1342 · Cited by 31
“Major thoracic diseases such as lung cancer and tuberculosis are among the leading causes of death worldwide (28,29), and numerous radiologic studies have been performed to diagnose them.”
BackgroundGhaffarlou, M., Mohammadi, A., Mousazadeh, N., Salehiabar, M., Kalantari, Y., Charmi, J., Barsbay, M., Ertas, Y. N., Danafar, H., Rezaeejam, H., et al. (2023) · Scientific Reports · doi:10.1038/s41598-023-40763-9 · Cited by 20
Taurisano, P., Abbatantuono, C., Verri, V., Pepe, I., Stucci, L. S., Taurino, A., Moschetta, M., De Caro, M. F., & Antonucci, L. A. (2022) · BMC Psychology · doi:10.1186/s40359-021-00714-3 · Cited by 19
Iqbal, H., Inam‐Ur‐Raheem, M., Munir, S., Rabail, R., Kafeel, S., Shahid, A., Mousavi Khaneghah, A., & Aadil, R. M. (2024) · Food Science & Nutrition · doi:10.1002/fsn3.3869 · Cited by 19
Li, W., Zhou, Y., Deng, Y., & Khoo, B. L. (2022) · Cancers · doi:10.3390/cancers14030818 · Cited by 15
Evaluating the Effectiveness of Mobile Health in Breast Cancer Care: A Systematic Review
Flaucher, M., Zakreuskaya, A., Nissen, M., Mocker, A., Fasching, P. A., Beckmann, M. W., Eskofier, B. M., & Leutheuser, H. (2023) · The Oncologist · doi:10.1093/oncolo/oyad217 · Cited by 15
“(1) Export of Data (2) Gamification (3) General Education (4) Tailored Education (5) Plan or Orders (6) Reminder (7) Community Forum (9) Tracker (8) Addresses Symptoms”
BackgroundMethodInfluentialZhou, B., Gek Mui, L., Li, J., & Hu, J. (2024) · Patient Education and Counseling · doi:10.1016/j.pec.2024.108353 · Cited by 13
Yu, C., Zong, H., Chen, Y., Zhou, Y., Liu, X., Lin, Y., Li, J., Zheng, X., Min, H., & Shen, B. (2024) · Briefings in Bioinformatics · doi:10.1093/bib/bbae136 · Cited by 13
Yuyan, Y., Jiaqi, L., Ting, W., Juan, X., Jinfeng, W., & Jing, L. (2025) · European Journal of Oncology Nursing · doi:10.1016/j.ejon.2025.102862 · Cited by 11
Explaining the interaction of mangiferin with MMP-9 and NF-ƙβ: a computational study
Gálvez-Rodríguez, A., Ferino-Pérez, A., Rodríguez-Riera, Z., Rodeiro Guerra, I., Řeha, D., Minofar, B., & Jáuregui-Haza, U. J. (2022) · Journal of Molecular Modeling · doi:10.1007/s00894-022-05260-2 · Cited by 9
Chen, D., Liu, Q., Zhang, L., & Qian, H. (2025) · Cancer Nursing · doi:10.1097/ncc.0000000000001307 · Cited by 8
Gebremeskel, T. G., Romeo, F., Shama, A. T., Bonevski, B., & Trigg, J. (2024) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph21050534 · Cited by 6
Lakshmanan, J., Jaganathan, V. L., Zhang, B., Werner, G., Allen, T. S., Schultz, D. J., Klinge, C. M., & Harbrecht, B. G. (2025) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/0118715206327789241008162423 · Cited by 5
Gálvez-Rodríguez, A., Ferino-Pérez, A., Rodríguez-Riera, Z., Guerra, I. R., & Jáuregui-Haza, U. J. (2023) · Journal of Molecular Graphics and Modelling · doi:10.1016/j.jmgm.2023.108569 · Cited by 2
Metadata
- Authors
- Ferlay, J., Colombet, M., Soerjomataram, I., Parkin, D. M., Piñeros, M., Znaor, A., & Bray, F.
- Venue
- International Journal of Cancer
- Publisher
- Wiley
- Published
- 2021-04-22
- Volume
- 149
- Issue
- 4
- Pages
- 778-789
- ISSN
- 0020-7136 (ISSN-L)
- 1097-0215
- OpenAlex
- W3147142721
- Cited by
- 5,689
- References
- 10
- FWCI
- 328.33
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.